Company Filing History:
Years Active: 1998
Title: Suresh K Arya: Innovator in HIV Research
Introduction
Suresh K Arya is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in HIV research. His work has implications for understanding and potentially treating HIV infections.
Latest Patents
Suresh K Arya holds 1 patent related to his research. The patent is titled "Nucleic acid encoding HIV-1 tat protein." This invention describes a nucleic acid encoding a functional HTLV-III/LAV (HIV-1) protein that possesses trans-activating ability. Additionally, it includes expression vectors that comprise this nucleic acid, showcasing the innovative approach Arya has taken in his research.
Career Highlights
Throughout his career, Suresh K Arya has worked with prestigious organizations. He has been associated with the Dana-Farber Cancer Institute and the United States of America as represented by the Department of Health. His work in these institutions has allowed him to contribute to significant advancements in cancer and HIV research.
Collaborations
Suresh K Arya has collaborated with prominent figures in the field, including William A Haseltine and Craig A Rosen. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Suresh K Arya's contributions to HIV research through his innovative patent and collaborations with esteemed colleagues highlight his role as a significant inventor in the biotechnology field. His work continues to influence the understanding of HIV and its treatment options.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.